Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Aptalis Pharma Inc | m67124exv21w1.htm |
| EX-32.1 - EX-32.1 - Aptalis Pharma Inc | m67124exv32w1.htm |
| EX-12.1 - EX-12.1 - Aptalis Pharma Inc | m67124exv12w1.htm |
| 10-K - 10-K - Aptalis Pharma Inc | m67124e10vk.htm |
| EX-31.1 - EX-31.1 - Aptalis Pharma Inc | m67124exv31w1.htm |
| EX-31.2 - EX-31.2 - Aptalis Pharma Inc | m67124exv31w2.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Axcan Intermediate Holdings Inc. (the
“Company”) for the period ending September 30, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Steve Gannon, Senior Vice President and Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to
section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
A signed original of this written statement has been provided to the Company and will be
retained by the Company and furnished to the SEC or its staff upon request.
Date: December 16, 2010
| /s/ Steve Gannon | ||||
| Steve Gannon | ||||
| Senior Vice President and Chief Financial Officer | ||||